NL6409714A
(sl)
*
|
1962-10-30 |
1965-10-01 |
|
|
US3472848A
(en)
*
|
1966-11-17 |
1969-10-14 |
Merck & Co Inc |
3-hydroxy and 3-mercapto-pyrazinoyl-guanidines,corresponding ethers and thioethers and processes for their preparation
|
US3948895A
(en)
*
|
1971-09-28 |
1976-04-06 |
E. I. Du Pont De Nemours And Company |
Synthesis of 3,5-diaminopyrazinoic acid from 3,5-diamino-2,6-dicyanopyrazine and intermediates
|
US4085211A
(en)
*
|
1975-12-15 |
1978-04-18 |
Merck & Co., Inc. |
Pyrazinecarboxamides and processes for preparing same
|
US4087526A
(en)
*
|
1976-07-23 |
1978-05-02 |
Merck & Co., Inc. |
(3-Amino-5-substituted-6-fluoropyrazinoyl or pyrazamido)-guanidines and their derivatives bearing substituents on the guanidino nitrogens
|
US4208413A
(en)
*
|
1977-03-04 |
1980-06-17 |
Merck & Co., Inc. |
N-Pyrazinecarbonyl-N'-alkoxycarbonyl and N',N"-bis(alkoxycarbonyl)guanidines and processes for preparing same
|
US4108859A
(en)
*
|
1977-06-06 |
1978-08-22 |
The Dow Chemical Company |
Microbicidal (pyridinylamino) alkyl guanidines
|
US4140776A
(en)
*
|
1977-09-16 |
1979-02-20 |
Merck & Co., Inc. |
N-pyrazinecarbonyl-N'-acylguanidines
|
US4190655A
(en)
*
|
1978-08-28 |
1980-02-26 |
Merck & Co., Inc. |
Amiloride citrate
|
EP0009054A1
(en)
*
|
1978-09-19 |
1980-04-02 |
Merck & Co. Inc. |
N-Pyrazinecarbonyl-N'-substituted-sulfamoyl-guanidine and processes for preparing same
|
US4224447A
(en)
*
|
1979-03-27 |
1980-09-23 |
Merck & Co., Inc. |
Novel pyrazinecarboxamides and processes for preparing same
|
US4246406A
(en)
*
|
1979-03-27 |
1981-01-20 |
Merck & Co., Inc. |
Heterocyclic substituted pyrazinoylguanidines
|
US4309540A
(en)
*
|
1980-05-19 |
1982-01-05 |
Merck & Co., Inc. |
Substituted pyrazinyl-1,2,4-oxadiazoles
|
US4362724A
(en)
*
|
1980-05-19 |
1982-12-07 |
Merck & Co., Inc. |
Method of treating edema and hypertension and pharmaceutical composition therefor in which the active ingredient comprises a novel substituted pyrazinyl-1,2,4-oxadiazole and a kaliuretic diuretic
|
US4454132A
(en)
*
|
1981-03-16 |
1984-06-12 |
Merck & Co., Inc. |
Pharmaceutical compositions of novel substituted pyrazinyl-1,2,4-oxadiazoles useful in the treatment of edema and hypertension
|
US4510322A
(en)
*
|
1981-07-13 |
1985-04-09 |
Merck & Co., Inc. |
Indacrinone having enhanced uricosuric
|
US4952582A
(en)
*
|
1982-01-04 |
1990-08-28 |
Beyer Jr Karl H |
Pyrazinoylguanidine and derivatives thereof having few polar substituents and being useful as hyperuretic agents
|
US4663322A
(en)
*
|
1982-01-04 |
1987-05-05 |
Beyer Jr Karl H |
Antihypertensive hyperuretic and saluretic agent combinations
|
DE3312516A1
(de)
*
|
1983-04-07 |
1984-10-11 |
Brigitte Dr. 7400 Tübingen Pfeiffer |
Kernsubstituierte phenylalkylenguanidinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
|
US4604394A
(en)
*
|
1984-10-01 |
1986-08-05 |
Merck & Co., Inc. |
Antiarrhythmic compositions and method
|
DE3925847A1
(de)
*
|
1989-08-04 |
1991-02-07 |
Huels Chemische Werke Ag |
Verfahren zur herstellung von 3-aminopyrazin-2-carbonsaeuremethylester
|
US5304125A
(en)
*
|
1990-10-05 |
1994-04-19 |
The University Of North Carolina |
Apparatus for administering solid particulate aerosols to the lungs
|
JP3481236B2
(ja)
*
|
1990-10-05 |
2003-12-22 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
固体粒状薬剤及び固体粒状薬剤エーロゾル投薬装置
|
TW213903B
(sl)
*
|
1991-08-16 |
1993-10-01 |
Boehringer Ingelheim Kg |
|
US6169107B1
(en)
|
1993-04-28 |
2001-01-02 |
Sumitomo Pharmaceutical Co., Ltd. |
Indoloylguanidine derivatives
|
DE4337609A1
(de)
*
|
1993-11-04 |
1995-05-11 |
Boehringer Ingelheim Kg |
Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
|
US5656256A
(en)
*
|
1994-12-14 |
1997-08-12 |
The University Of North Carolina At Chapel Hill |
Methods of treating lung disease by an aerosol containing benzamil or phenamil
|
TW372967B
(en)
*
|
1994-12-27 |
1999-11-01 |
Kanebo Ltd |
1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof
|
US5635160A
(en)
*
|
1995-06-07 |
1997-06-03 |
The University Of North Carolina At Chapel Hill |
Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
|
US5628984A
(en)
|
1995-07-31 |
1997-05-13 |
University Of North Carolina At Chapel Hill |
Method of detecting lung disease
|
US5801177A
(en)
*
|
1995-12-14 |
1998-09-01 |
Beyer, Jr.; Karl H. |
Method for controlling and/or lowering serum glucose and fatty acid concentrations and hypertensive blood pressure in non-insulin-dependent diabetic patients
|
US5877217A
(en)
*
|
1995-12-26 |
1999-03-02 |
Alteon Inc. |
N-acylaminoalkyl-hydrazinecarboximidamides
|
DE69828892D1
(de)
*
|
1997-08-29 |
2005-03-10 |
Univ North Carolina |
Verwendung von uridin-5'-diphosphat und analoge zur behandlung von lungenerkrankungen
|
JP2002527459A
(ja)
*
|
1998-10-20 |
2002-08-27 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
粘膜表面を水和する方法
|
EP1161242A4
(en)
*
|
1999-01-29 |
2004-06-30 |
Beyer Camille F |
COMPOSITION AND METHOD FOR TREATING DIABETES
|
DK1196396T3
(da)
|
1999-07-19 |
2008-07-14 |
Univ North Carolina |
Farmakologisk aktive forbindelser med to kovalent bundne aktive principper (natrium-kanalblokker/P2Y2-receptoragonist) til behandling af slimhindeoverflader
|
ES2262689T3
(es)
|
2000-11-21 |
2006-12-01 |
Sankyo Company, Limited |
Composicion que contiene un antagonista del receptor de angiotensina ii y un diuretico y su uso para el tratamiento de la hipertension.
|
US6858615B2
(en)
*
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenyl guanidine sodium channel blockers
|
US6858614B2
(en)
*
|
2002-02-19 |
2005-02-22 |
Parion Sciences, Inc. |
Phenolic guanidine sodium channel blockers
|
US7704995B2
(en)
*
|
2002-05-03 |
2010-04-27 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
AU2003234464B2
(en)
*
|
2002-05-03 |
2009-06-04 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
OA12905A
(en)
|
2002-08-19 |
2006-10-13 |
Pfizer Prod Inc |
Combination therapy for hyperproliferative diseases.
|
US6903105B2
(en)
*
|
2003-02-19 |
2005-06-07 |
Parion Sciences, Inc. |
Sodium channel blockers
|
AU2004248859C1
(en)
*
|
2003-06-26 |
2011-11-24 |
Biotron Limited |
Antiviral acylguanidine compounds and methods
|
JP5030587B2
(ja)
*
|
2003-06-26 |
2012-09-19 |
バイオトロン・リミテッド |
抗ウイルスアシルグアニジン化合物および方法
|
US7326706B2
(en)
*
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
JP2007502827A
(ja)
*
|
2003-08-18 |
2007-02-15 |
パリオン・サイエンシィズ・インコーポレーテッド |
脂肪族ピラジノイルグアニジンナトリウムチャネルブロッカー
|
US20050090505A1
(en)
*
|
2003-08-18 |
2005-04-28 |
Johnson Michael R. |
Methods of reducing risk of infection from pathogens
|
JP4805824B2
(ja)
|
2003-08-18 |
2011-11-02 |
パリオン・サイエンシィズ・インコーポレーテッド |
キャップ化ピラジノイルグアニジンナトリウムチャネルブロッカー
|
US20090253714A1
(en)
*
|
2003-08-20 |
2009-10-08 |
Johnson Michael R |
Methods of reducing risk of infection from pathogens
|
US7745442B2
(en)
|
2003-08-20 |
2010-06-29 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens
|
US20070099968A1
(en)
*
|
2004-06-26 |
2007-05-03 |
Biotron Limited |
Antiviral compounds and methods
|
US20070021439A1
(en)
*
|
2005-07-25 |
2007-01-25 |
Parion Sciences, Inc. |
Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
CA2630920A1
(en)
*
|
2005-11-22 |
2007-05-31 |
University Of South Florida |
Inhibition of cell proliferation
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
US8404896B2
(en)
|
2006-12-01 |
2013-03-26 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
AU2008310734B2
(en)
|
2007-10-10 |
2014-06-05 |
Parion Sciences, Inc. |
Delivering osmolytes by nasal cannula
|
CA2713413C
(en)
|
2008-02-26 |
2018-11-20 |
Parion Sciences, Inc. |
Poly aromatic sodium channel blockers
|
DE102008053024B4
(de)
|
2008-10-24 |
2015-04-30 |
RUHR-UNIVERSITäT BOCHUM |
Verwendung von Amilorid-Derivaten zur Bekämpfung von Insekten und Milben
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
US8945605B2
(en)
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
PT2723176T
(pt)
|
2011-06-27 |
2017-07-18 |
Parion Sciences Inc |
Dipéptido química e metabolicamente estável que possui potente atividade bloqueadora do canal de sódio
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
JP6272312B2
(ja)
|
2012-05-29 |
2018-01-31 |
パリオン・サイエンシィズ・インコーポレーテッド |
ドライアイおよび他の粘膜疾患の治療のためのナトリウムチャネル遮断活性を有するデンドリマー様アミノアミド
|
EP2931712B8
(en)
|
2012-12-17 |
2018-05-23 |
Parion Sciences, Inc. |
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
|
AP2015008556A0
(en)
|
2012-12-17 |
2015-06-30 |
Parion Sciences Inc |
Chloro-pyrazine carboxamide derivatives useful forthe treatment of diseases favoured by insufficien t mucosal hydration
|
JP2016516804A
(ja)
|
2013-04-17 |
2016-06-09 |
ファイザー・インク |
心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体
|
EP3019492B1
(en)
*
|
2013-07-08 |
2017-09-06 |
Boehringer Ingelheim International GmbH |
Amiloride-type compounds as inhibitors in epithelial sodium channels for the treatment of diseases of the lungs and airways
|
US9102633B2
(en)
|
2013-12-13 |
2015-08-11 |
Parion Sciences, Inc. |
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
US10662156B2
(en)
|
2016-07-29 |
2020-05-26 |
Toray Industries, Inc. |
Guanidine derivative and medical use thereof
|
JOP20210193A1
(ar)
|
2019-01-18 |
2023-01-30 |
Astrazeneca Ab |
مثبطات pcsk9 وطرق استخدامها
|